Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Nov 24 | AUPH Aurinia Pharmaceuticals | Common Shares | Grant | Acquire A | No | No | 0 | 12,135 | 0.00 | 24,807 |
21 Nov 24 | AUPH Aurinia Pharmaceuticals | Director Stock Option Common Shares | Grant | Acquire A | No | No | 8.24 | 18,641 | 153.60 k | 18,641 |
11 Nov 24 | AUPH Aurinia Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 8.43 | 5,241 | 44.18 k | 12,672 |
8 Nov 24 | AUPH Aurinia Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 17,913 | 0.00 | 17,913 |
8 Nov 24 | AUPH Aurinia Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 17,913 | 0.00 | 0 |
28 Oct 24 | SKYE Skye Bioscience | Stock Option Common Stock | Grant | Acquire A | No | No | 5.15 | 70,000 | 360.50 k | 70,000 |
4 Sep 24 | CNTX Context Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.43 | 19,315 | 46.94 k | 19,315 |